Top Markets
#1 DogBull DogBull +107.30%
#2 MarsCoin MarsCoin +62.81%
#3 Siacoin Siacoin +51.84%
#4 ADO Protocol ADO Protocol +51.50%
#5 Ontology Gas Ontology Gas +24.09%
#6 The Bitcoin Bull The Bitcoin Bull +17.18%
#7 Useless Coin Useless Coin +14.86%
#8 Apertum Apertum +14.84%
#9 Nockchain Nockchain +12.03%
#10 UnifAI Network UnifAI Network +11.58%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rang in Aktien #15162
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Aktienkurs
$1.98
Marktkapitalisierung
$368.99M
Veränderung (1 Tag)
0.90%
Veränderung (1 Jahr)
11.38%
Land
AU
Handel Australian Clinical Labs Limited (ACL)

Kategorie

Healthcare
P/S-Verhältnis für Australian Clinical Labs Limited (ACL)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Australian Clinical Labs Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Australian Clinical Labs Limited von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.95 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.98 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
17.03 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.64 -
US